Patents by Inventor Sugyeong Kwon

Sugyeong Kwon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • QUINAZOLINE-2,4-DIAMINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING SAME AS ACTIVE INGREDIENT
    Publication number: 20230365530
    Abstract: A compound, a stereoisomer thereof, a hydrate thereof, or a pharmaceutically acceptable salt thereof, provided as one aspect of the present invention, exhibits a high inhibitory ability on euchromatic histone-lysine N-methyltransferase 2 (EHMT2), and thus, the compound can be usefully used for the treatment of cancer.
    Type: Application
    Filed: September 16, 2021
    Publication date: November 16, 2023
    Inventors: Jung Jin HWANG, Sang Eun PARK, Dong Eun KIM, Ji-Ye HONG, Choung-Soo KIM, Woo Chan SON, Shinae KIM, Sugyeong KWON, Kyungjin JUNG, Nayeon KIM, Jina KIM, Kyung-Hee KIM, Jung Wook CHIN, Sung Jin CHO, Sehan LEE, Eunju CHA, Jeongmin JOO, Ji Sun HWANG, Jeong-Eun PARK, Ji Hoon YU, Eunmi HONG, Young-Hoon PARK, Ju-Hee LEE
  • NOVEL N-ACYLUREA DERIVATIVE AND COMPOSITION COMPRISING SAME FOR PREVENTION OR TREATMENT OF CARDIOVASCULAR DISEASE
    Publication number: 20220194928
    Abstract: The present invention relates to a novel N-acylurea derivative and the use thereof for the prevention or treatment of cardiovascular disease, and more particularly to a novel N-acylurea derivative, a pharmaceutical composition for prevention or treatment of cardiovascular disease, which contains the N-acylurea derivative as an active ingredient, and a method of preparing the N-acylurea derivative. The N-acylurea derivative according to the present invention can inhibit platelet aggregation by inhibiting the activity of talin in the intracellular matrix, and thus can be useful for the prevention or treatment of cardiovascular disease.
    Type: Application
    Filed: March 10, 2022
    Publication date: June 23, 2022
    Inventors: Soon Jun Hong, Chung Ho Kim, Hyung Joon Joo, Jong-Ho Kim, Ji-Young Park, Seung Cheol Choi, Chan-Sik Yang, Jong Hwa Jung, Minseon Jeong, Miseon Ryu, Sugyeong Kwon
  • N-acylurea derivative and composition comprising same for prevention or treatment of cardiovascular disease
    Patent number: 11306073
    Abstract: The present invention relates to a novel N-acylurea derivative and the use thereof for the prevention or treatment of cardiovascular disease, and more particularly to a novel N-acylurea derivative, a pharmaceutical composition for prevention or treatment of cardiovascular disease, which contains the N-acylurea derivative as an active ingredient, and a method of preparing the N-acylurea derivative. The N-acylurea derivative according to the present invention can inhibit platelet aggregation by inhibiting the activity of talin in the intracellular matrix, and thus can be useful for the prevention or treatment of cardiovascular disease.
    Type: Grant
    Filed: December 22, 2016
    Date of Patent: April 19, 2022
    Assignees: KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION, KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERTION FOUNDATION
    Inventors: Soon Jun Hong, Chung Ho Kim, Hyung Joon Joo, Jong-Ho Kim, Ji-Young Park, Seung Cheol Choi, Chan-Sik Yang, Jong Hwa Jung, Minseon Jeong, Miseon Ryu, Sugyeong Kwon
  • NOVEL N-ACYLUREA DERIVATIVE AND COMPOSITION COMPRISING SAME FOR PREVENTION OR TREATMENT OF CARDIOVASCULAR DISEASE
    Publication number: 20190119261
    Abstract: The present invention relates to a novel N-acylurea derivative and the use thereof for the prevention or treatment of cardiovascular disease, and more particularly to a novel N-acylurea derivative, a pharmaceutical composition for prevention or treatment of cardiovascular disease, which contains the N-acylurea derivative as an active ingredient, and a method of preparing the N-acylurea derivative. The N-acylurea derivative according to the present invention can inhibit platelet aggregation by inhibiting the activity of talin in the intracellular matrix, and thus can be useful for the prevention or treatment of cardiovascular disease.
    Type: Application
    Filed: December 22, 2016
    Publication date: April 25, 2019
    Inventors: Soon Jun Hong, Chung Ho Kim, Hyung Joon Joo, Jong-Ho Kim, Ji-Young Park, Seung Cheol Choi, Chan-Sik Yang, Jong Hwa Jung, Minseon Jeong, Miseon Ryu, Sugyeong Kwon